IDT Partners with Profluent Bio to Develop AI-Designed Enzymes
The collaboration combines Profluent’s generative AI platform with IDT’s enzyme engineering and genomics expertise to accelerate development of next-generation enzymes.
The collaboration combines Profluent’s generative AI platform with IDT’s enzyme engineering and genomics expertise to accelerate development of next-generation enzymes.
The USPTO granted Sherlock Biosciences a patent for the diagnostic use of the Cas12 enzyme, establishing it as CRISPR diagnostics provider.
Technology developed by scientists at Lawrence Berkeley National Laboratory shows promise for diagnosing Alzheimer’s disease before symptoms arise.